UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 76

Sortiert nach

Therapeutic drug monitoring of olanzapine: The combined effect of age, gender, smoking, and comedication

Therapeutic drug monitoring, 2003-02, Vol.25 (1), p.46-53

2003

Volltextzugriff (PDF)

Physiologically based pharmacokinetics in drug development and regulatory science: a workshop report (Georgetown University, Washington, DC, May 29-30, 2002)

AAPS PharmSci, 2004-02, Vol.6 (1), p.E6-67

2004

Volltextzugriff (PDF)

Time course of clinical response to venlafaxine: relevance of plasma level and chirality

European journal of clinical pharmacology, 2004-02, Vol.59 (12), p.883-891

2004

Volltextzugriff (PDF)

Steady-state concentration of venlafaxine enantiomers: model-based analysis of between-patient variability

European journal of clinical pharmacology, 2002-08, Vol.58 (5), p.323-331

2002

Volltextzugriff (PDF)

Therapeutic drug monitoring of risperidone using a new, rapid HPLC method : Reappraisal of interindividual variability factors

Therapeutic drug monitoring, 1999-02, Vol.21 (1), p.105-115

1999

Volltextzugriff (PDF)

Modelling during drug development

European Journal of Pharmaceutics and Biopharmaceutics, 2000-07, Vol.50 (1), p.13-26

2000

Volltextzugriff (PDF)

Therapeutic drug monitoring databases for postmarketing surveillance of drug-drug interactions

Drug safety, 2001, Vol.24 (13), p.947-959

2001

Volltextzugriff (PDF)

The use of population pharmacokinetics in drug development

Clinical pharmacokinetics, 1996-02, Vol.30 (2), p.81-93

1996

Volltextzugriff (PDF)

Investigation of xenobiotic metabolism by CYP2D6 and CYP2C19: importance of enantioselective analytical methods

Journal of Chromatography B: Biomedical Sciences and Applications, 1996-03, Vol.678 (1), p.73-92

1996

Volltextzugriff (PDF)

New Alterations of Serum Glycoproteins in Alcoholic and Cirrhotic Patients Revealed by High Resolution Two-Dimensional Gel Electrophoresis

Biochemical and biophysical research communications, 1996-03, Vol.220 (1), p.78-85

1996

Volltextzugriff (PDF)

Action COST B15: Modelling During Drug Development

Basic & clinical pharmacology & toxicology, 2005-03, Vol.96 (3), p.149-150

Balant, Luc

2005

Volltextzugriff (PDF)

Population pharmacokinetics of clomipramine, desmethylclomipramine, and hydroxylated metabolites in patients with depression receiving chronic treatment : Model evaluation

Therapeutic drug monitoring, 2000-12, Vol.22 (6), p.701-711

2000

Volltextzugriff (PDF)

Action COST B15 : Modelling during drug development October 1998 to July 2004

Basic & clinical pharmacology & toxicology, 2005-03, Vol.96 (3), p.149-150

BALANT, Luc

2005

Volltextzugriff (PDF)

Rapid detection of the main human plasma glycoproteins by two-dimensional polyacrylamide gel electrophoresis lectin affinoblotting

Electrophoresis, 1995, Vol.16 (1), p.1187-1189

1995

Volltextzugriff (PDF)

Enantioselective analysis of methadone in saliva by liquid chromatography–mass spectrometry

Journal of Chromatography A, 2000-02, Vol.871 (1), p.163-172

2000

Volltextzugriff (PDF)

Gd-BOPTA Transport Into Rat Hepatocytes: Pharmacokinetic Analysis of Dynamic Magnetic Resonance Images Using a Hollow-Fiber Bioreactor

Investigative radiology, 2004-08, Vol.39 (8), p.506-515

2004

Volltextzugriff (PDF)

COST B15: modelling in drug development

British journal of clinical pharmacology, 2001-07, Vol.52 (1), p.118-119

2001

Volltextzugriff (PDF)

Clinical pharmacokinetics of clomipramine

Clinical pharmacokinetics, 1991-06, Vol.20 (6), p.447-462

1991

Volltextzugriff (PDF)

Basis for dosing time-dependent changes in the ocular and systemic absorption of topically applied timolol

Journal of ocular pharmacology and therapeutics, 1996, Vol.12 (2), p.103-113

1996

Volltextzugriff (PDF)

Pharmacokinetics: Regulatory-industrial-academic perspectives

European journal of pharmaceutics and biopharmaceutics, 1997-04, Vol.43 (2), p.202

Balant, Luc P.

1997

Volltextzugriff (PDF)

Quantification of Gd-BOPTA Uptake and Biliary Excretion From Dynamic Magnetic Resonance Imaging in Rat Livers: Model Validation With 153Gd-BOPTA

Investigative radiology, 2005-11, Vol.40 (11), p.705-714

2005

Volltextzugriff (PDF)

Dealing with Metabolic Variability during Drug Development

Computer‐Assisted Lead Finding and Optimization, 1997, p.313-331

1997

Volltextzugriff (PDF)

Therapeutic Drug Monitoring: Relevance During the Drug Treatment of Psychiatric Disorders

CNS drugs, 1995-12, Vol.4 (6), p.432-453

1995

Volltextzugriff (PDF)

Comparative pharmacokinetic study of a floating multiple-unit capsule, a high-density multiple-unit capsule and an immediate-release tablet containing 25 mg atenolol

Pharmaceutica acta Helvetiae, 1998-07, Vol.73 (2), p.81-87

1998

Volltextzugriff (PDF)

Clomipramine metabolism. Model-based analysis of variability factors from drug monitoring data

Clinical pharmacokinetics, 1990-09, Vol.19 (3), p.241-255

1990

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(43)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(48)
Science & Technology
(33)
Life Sciences & Biomedicine
(31)
Biological And Medical Sciences
(22)
Medical Sciences
(21)
Male
(20)
Pharmacology & Pharmacy
(20)
Pharmacology. Drug Treatments
(19)
Animals
(17)
Adult
(15)
Female
(15)
Middle Aged
(15)
Aged
(10)
Kinetics
(9)
Depressive Disorder - Drug Therapy
(7)
Pharmacokinetics
(7)
Psychology. Psychoanalysis. Psychiatry
(7)
Toxicology
(7)
Chemistry
(6)
Dose-Response Relationship, Drug
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Therapeutic drug monitoring of olanzapine: The combined effect of age, gender, smoking, and comedication

Physiologically based pharmacokinetics in drug development and regulatory science: a workshop report (Georgetown University, Washington, DC, May 29-30, 2002)

Time course of clinical response to venlafaxine: relevance of plasma level and chirality

Steady-state concentration of venlafaxine enantiomers: model-based analysis of between-patient variability

Therapeutic drug monitoring of risperidone using a new, rapid HPLC method : Reappraisal of interindividual variability factors

Modelling during drug development

Therapeutic drug monitoring databases for postmarketing surveillance of drug-drug interactions

The use of population pharmacokinetics in drug development

Investigation of xenobiotic metabolism by CYP2D6 and CYP2C19: importance of enantioselective analytical methods

New Alterations of Serum Glycoproteins in Alcoholic and Cirrhotic Patients Revealed by High Resolution Two-Dimensional Gel Electrophoresis

Action COST B15: Modelling During Drug Development

Population pharmacokinetics of clomipramine, desmethylclomipramine, and hydroxylated metabolites in patients with depression receiving chronic treatment : Model evaluation

Action COST B15 : Modelling during drug development October 1998 to July 2004

Rapid detection of the main human plasma glycoproteins by two-dimensional polyacrylamide gel electrophoresis lectin affinoblotting

Enantioselective analysis of methadone in saliva by liquid chromatography–mass spectrometry

Gd-BOPTA Transport Into Rat Hepatocytes: Pharmacokinetic Analysis of Dynamic Magnetic Resonance Images Using a Hollow-Fiber Bioreactor

COST B15: modelling in drug development

Clinical pharmacokinetics of clomipramine

Basis for dosing time-dependent changes in the ocular and systemic absorption of topically applied timolol

Pharmacokinetics: Regulatory-industrial-academic perspectives

Quantification of Gd-BOPTA Uptake and Biliary Excretion From Dynamic Magnetic Resonance Imaging in Rat Livers: Model Validation With 153Gd-BOPTA

Dealing with Metabolic Variability during Drug Development

Therapeutic Drug Monitoring: Relevance During the Drug Treatment of Psychiatric Disorders

Comparative pharmacokinetic study of a floating multiple-unit capsule, a high-density multiple-unit capsule and an immediate-release tablet containing 25 mg atenolol

Clomipramine metabolism. Model-based analysis of variability factors from drug monitoring data

Suchergebnisse filtern